A nanoparticle-based therapy delivered directly to the mammary ducts could potentially stop precancerous cells from becoming full-blown breast cancer. In mice, the treatment shut down a gene involved in unchecked cancer growth, researchers report January 1 in Science Translational Medicine.
Note: To comment, Science News subscribing members must now establish a separate login relationship with Disqus. Click the Disqus icon below, enter your e-mail and click “forgot password” to reset your password. You may also log into Disqus using Facebook, Twitter or Google.